Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Oculis Reports Q1 Financial Results and Provides Company Update
The recent R&D Day ( replay ) showcased material progress across all three core assets and highlighted potential first-in-class neuroprotection treatment in neuro-ophthalmology, an area of high unmet medical need, thanks to Privosegtor's (OCS-05) positive results from the ACUITY trial in Acute Optic NeuritisOCS-01: DIAMOND Ph3 trials enrollment completed with over 800 patients randomized; topline results expected Q2 2026 for the first potential eye drop treatment for diabetic...
Nasdaq GlobeNewswire
08/05/2025
Women's Health Therapeutics Market Poised for Growth: Innovation, Investment and…
According to the report, growing emphasis on personalized medicine and biologics is reshaping corporate strategies, especially as North America leads global expansion and emerging technologies unlock new care models. While the market is projected to grow at a CAGR of 5.7% from 2024 to 2029, stakeholders must navigate regulatory hurdles and rising treatment costs to capture long-term value. This shift marks a profound transformation in how biotech investors, manufacturers, and healthcare…
PR Newswire
08/05/2025
Inside information: Bioretec´s CEO Alan Donze to resign
The Board of Directors of Bioretec would like to thank Alan Donze for his work as CEO. The Board of Directors of Bioretec would like to thankAlan Donzefor his work as CEO. The Board of Directors will immediately initiate the process of recruiting a new CEO. Further enquiriesKustaa Poutiainen, Chair of the Board, +358 40 042 4506 Certified adviserNordic Certified Adviser AB, +46 70 551 67 29 Bioretec in brief Bioretec is a globally operating Finnish medical device...
PR Newswire
08/05/2025
Philips shareholders approve all proposals at the AGM 2025
Amsterdam, the Netherlands – Royal Philips(NYSE: PHG, AEX: PHIA), today announced that its shareholders approved all proposals at the Annual General Meeting of Shareholders (AGM) 2025, including: The re-appointment of Ms Indra Nooyi and Ms Chua Sock Koong as members of the Supervisory Board.The appointment of Mr Bob White as a new member of the Supervisory Board.The re-appointment of Mr Marnix van Ginneken as member of the Board of Management. The discharge of the members of...
Nasdaq GlobeNewswire
08/05/2025
Clue Launches "Connect the Dots" Campaign for Mental Health Awareness Month…
Clue , the most trusted, data-driven period and reproductive health tracking app, today announced its "Connect the Dots" campaign for Mental Health Awareness Month. The campaign highlights the critical, yet often overlooked connection between menstrual cycles and mental health. Additionally, with 90% of Clue members agreeing that tracking with Clue helps them better understand their body patterns, the campaign will focus on how cycle tracking can better help people understand their…
Nasdaq GlobeNewswire
08/05/2025
Press release: Transparency Notification from Shareholders
Transparency Notification from ShareholdersGhent, Belgium – 8 May 2025 – Sequana Medical NV (Euronext Brussels: SEQUA)(the " Company " or " SequanaMedical "), a pioneer in the treatment of drug-resistant fluid overload in liver disease, heart failure and cancer, announces today that it received a transparency notification in relation to the entities listed below, notifying the number of voting rights attached to the shares mentioned next to their name in the table below…
Nasdaq GlobeNewswire
08/05/2025
Blue Light Blocking Glasses Market to Reach $2.9 billion in 2024 in short term…
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A65843 Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A65843 Market Introduction Blue light blocking glasses are personalized eyewear designed to cater to individual preferences in style, fit, and functionality. Production involves advanced design software, 3D printing, or traditional manufacturing methods. Orders are placed online or...
PR Newswire
08/05/2025
Home Healthcare Market Poised to Reach $ 747.70 Billion by 2030 at CAGR 10.21% -…
Request a free sample copy or view report summary: Home Healthcare Market Request a free sample copy or view report summary:Home Healthcare Market The demand for home care services is expected to increase in the immediate future, owing to the ongoing COVID-19 pandemic. These services are safer and cost-effective alternatives to hospital services. External substitutes, including hospitals, informal care, and other healthcare establishments, pose a limited threat, mostly due to their high...
PR Newswire
08/05/2025
Genmab Announces Financial Results for the First Quarter of 2024
May 8, 2025 Copenhagen, Denmark;Interim Report for the First Quarter Ended March 31, 2025Highlights EPKINLY ®(epcoritamab) approved by the Japan Ministry of Health, Labour and Welfare (MHLW) for additional indication as a treatment for relapsed or refractory follicular lymphoma (FL)Rinatabart sesutecan (Rina-S ® ) continues to show encouraging antitumor activity in patients with advanced ovarian cancer in data presented at the 2025 Society of Gynecologic...
Nasdaq GlobeNewswire
08/05/2025
Microphysiological System Market Soars: USD 148M in 2024 to USD 1134M by 2031 at…
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-20K15201/Global_Microphysiological_System_Market. Get Free Sample:https://reports.valuates.com/request/sample/QYRE-Auto-20K15201/Global_Microphysiological_System_Market . Major Factors Driving the Growth Microphysiological System Market: The Microphysiological System (MPS) market is gaining momentum as a transformative tool in biomedical research, offering more accurate and human-relevant models compared to...
PR Newswire
08/05/2025
Closed Systems Transfer Devices Market worth US$2.09 billion by 2030 with 7.0%…
Browse in-depth TOC on "Closed Systems Transfer Devices Market" Browse in-depth TOC on "Closed Systems Transfer Devices Market" 273 - Tables 65 - Figures 289 - Pages By Based on type,the closed system transfer devices market is categorized into membrane-to-membrane systems and needleless systems. In 2023, the membrane-to-membrane systems segment held the largest share, by type. The high share and fast growth of this segment are due to their ease of use and lower rate of...
PR Newswire
08/05/2025
Hospital Asset Management Market is expected to generate a revenue of USD 414.18…
The hospital asset management market is gaining momentum as healthcare facilities embrace digital transformation. With rising investments in RFID, IoT, and cloud-based solutions, hospitals are optimizing workflows, reducing theft, and improving patient outcomes. The hospital asset management market is gaining momentum as healthcare facilities embrace digital transformation. With rising investments in RFID, IoT, and cloud-based solutions, hospitals are optimizing workflows, reducing theft, and...
PR Newswire
08/05/2025
MedTech Companies Paxman and Dignitana Announce Merger to Create a Stronger…
Paxman and Dignitana will now combine, creating a stronger, unified company - Paxman AB. This exciting merger will bring improved collaborations and connections, sharing new perspectives and strengths, working together as one team to improve patient outcomes. Paxman and Dignitana will now combine, creating a stronger, unified company - Paxman AB. This exciting merger will bring improved collaborations and connections, sharing new perspectives and strengths, working together as one team to...
PR Newswire
08/05/2025
Al in Pathology Market worth $347.4 million by 2030 with 26.5% CAGR |…
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=86647266 Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=86647266 Browse in-depth TOC on 'Al in Pathology Market' 269 - Tables 47 - Figures 292 - Pages By Based on segment,in 2024, the drug discovery segment accounted for the largest share of the market. This segment is also expected to grow at the highest CAGR during the forecast period. The increasing...
PR Newswire
08/05/2025
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities…
ORION CORPORATIONSTOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 8 May 2025 at 16:30 EEST Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has received a disclosure under Chapter 9, Section 5 of the Securities Market Act, according to which the total number of Orion shares owned directly, indirectly and through financial instruments by BlackRock, Inc. and its funds decreased on 7 May 2025 below...
Nasdaq GlobeNewswire
08/05/2025
Coloplast A/S - Trading in Coloplast shares by board members, executives or…
Please see enclosed pdf. Attachment 08052025_trading_in_shares_GL
Nasdaq GlobeNewswire
08/05/2025
ACTO APPOINTS FORMER J&J PRESIDENT TO ITS BOARD OF DIRECTORS
Tierney most recently served as President of Johnson & Johnson Vision and brings a wealth of experience from senior global and regional leadership roles at J&J MedTech and Mentor Aesthetics Specialty Surgery. Her career spans high-impact commercial leadership positions at AstraZeneca, Endo Pharmaceuticals, and Centocor, where she successfully led large-scale teams across global, strategic, and in-line marketing and sales. With a proven track record overseeing commercial operations…
PR Newswire
08/05/2025
Exidavnemab phase 2a study expanded to include MSA patients
The study is conducted in Spain and Poland. In addition to the 24 participants with mild to moderate Parkinson's Disease, an additional 12 participants with MSA will be recruited. In addition to the primary endpoints of safety and tolerability, a broad range of biomarkers will be evaluated, in plasma, cerebrospinal fluid (CSF) and using digital measurements. The study is conducted inSpainandPoland. In addition to the 24 participants with mild to moderate Parkinson's Disease, an...
PR Newswire
08/05/2025
Safe Life Acquires HeartCert in the US, Continues to Build Out National Coverage…
"We are truly excited to welcome HeartCert as new members of the Safe Life team," says Jimmy Eriksson, CEO of Safe Life. "CPR and First Aid training are core pillars for us, and we are extremely happy to add a Midwest growth engine and to see our network and delivery coverage strengthen nationally. I look forward to what we are going to be able to achieve together. Life-saving technology within the reach of trained members of the community is how we help save more lives."…
PR Newswire
08/05/2025
NAVEE Partners with Dott to Launch Next-Gen V1 Pro Scooter, Redefining Urban…
The V1 Pro revolutionizes fleet management, setting an unprecedented industry benchmark with 110+ days of standby time—surpassing competitors by more than two months. With an ultra-low static power consumption (<0.4W), it significantly reduces maintenance costs and ensures continuous fleet readiness. Its rapid 5-hour charging capability and powerful 1150Wh battery deliver over 110km of range, maximizing fleet availability and minimizing downtime in busy urban areas. The V1 Pro…
PR Newswire
08/05/2025
RECORDATI: STRONG MOMENTUM OF THE GROUP CONTINUES INTO THE FIRST QUARTER OF 2025…
Consolidated net revenue of € 680.0 million in the first quarter of 2025, +11.9% or +7.2% on a like-for-like basis (3)and at constant exchange rates (CER)EBITDA (1)of € 270.2 million, +10.7%, margin on revenue of 39.7% Adjusted net income (2)of € 175.5 million, +7.2% Net income of € 125.0 million, +1.2%Free cash flow (4)of € 158.8 million, +€ 11.7millionvs prior yearNet debt (5)at € 2,020.8 million, just below 2.2x EBITDA...
Nasdaq GlobeNewswire
08/05/2025
Bulletin from Sobi's Annual General Meeting (AGM)
The AGM adopted the income statements and the balance sheets and approved the proposal to carry forward the retained profits. The AGM adopted the income statements and the balance sheets and approved the proposal to carry forward the retained profits. The Board members and the chief executive officer were discharged from liability for the financial year 2024. Election of Board of Directors, remuneration to the Directors, election of Auditor and remuneration to the Auditor The...
PR Newswire
08/05/2025
Colorcon and ASHA Cellulose Announce New Partnership to Support the Development…
Raju Shah, President for ASHA Cellulose, commented: "Asha Cellulose has been involved in manufacturing ASHACEL Ethyl Cellulose and ASHAKOTE Aqueous Ethyl Cellulose dispersion using in-house capabilities and a world-class infrastructure. With this partnership, we are confident that the unique combination of our polymer expertise and Colorcon's technical prowess and customer reach will help us serve our customers better." Raju Shah, President for ASHA Cellulose, commented: "Asha…
PR Newswire
08/05/2025
Contour Design Signs Agreement to Acquire Active Key Business from Cherry SE
"This acquisition is a pivotal moment for Contour Design, aligning perfectly with our mission to enhance health and safety at workplaces," said Erik Stannow, Chairman of the Board at Contour Design. "Active Key's deep expertise in hygienic input devices complements our ergonomic strengths, allowing us to meet the growing demands of health-conscious industries." "This acquisition is a pivotal moment for Contour Design, aligning perfectly with our mission to enhance health…
PR Newswire
08/05/2025
Altri Comunicati